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1. Introduction 
Mycobacterium tuberculosis is a pathogenic bacteria species of the genus Mycobacterium, first 
discovered in 1882 by Robert Koch, which causes tuberculosis (TB) (Ryan & Ray, 2004). The 
disease is characterized by symptoms such as sepsis, septic shock, multiple organ failure 
(Muckart & Bhagwanjee, 1997). It may spread to the central nervous system and cause TB 
meningitis, intracranial tuberculomas, or abscesses (Harisinghani et al., 2000; Hwang et al., 
2010). 
After the late 1980s, tuberculosis morbidity and mortality rates became a major health 
problem for industrialized countries (Raviglione et al., 1995; Heym & Cole, 1997). 
Multidrug-resistant tuberculosis (MDR TB) and extensively drug resistant tuberculosis 
(XDR TB) has become a common phenomenon, which cause drugs to be ineffective. MDR-
TB results from either primary infection or may develop in the course of a patient's 
treatment. MDR TB is resistant to at least two first-line anti-TB drugs, isoniazid (INH) and 
rifampicin (RIF), which are most powerful anti-TB drugs; XDR TB is resistant to INH and 
RIF, plus fluoroquinolone and at least one of three injectable second-line drugs such as 
capreomycin, kanamycin, and amikacin. Treatment of XDR-TB is not possible by first-line 
anti-TB drugs, which are less effective, expensive and toxic; in addition treatment takes two 
years or more (WHO, 2011a; WHO, 2011b). 
Mycobacteria are resistant to most common antibiotics and chemotherapeutic agents due to 
the mycobacterial cell wall composition of bacterial peptidoglycans (Slayden & Barry, 2000; 
Lee et al., 1996; Brennan et al., 1995), a lipophilic layer of long-chain fatty acids, and mycolic 
acids (Barry et al., 1998). The rich lipids of the cell wall has an important role in their 
virulence (Murray, Rosenthal and Pfaller, 2005). This structure provides a highly 
hydrophobic and efficient barrier to antibiotics and chemotherapeutic agents (Jarlier & 
Nikaido 1994). Thus, this cell wall composition restricts the choice of drug treatment. 
Compounds capable of blocking efflux pumps so that antibiotics can gain access to their 
targets are of obvious importance (Viveiros et al, 2003). Increased activity of existing efflux 
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pumps were caused by ineffective therapy of TB patients, which is develops bacterial 
resistancy to one or more drug. Recent researches showed that mycobacteria have multiple 
putative efflux pumps which is a key factor for gaining resistance (Braibant, 2000; De Rossi 
et al., 2002). In addition to, chromosomal gene mutation and then accumulation of these 
mutations also one of the origine of multidrug-resistant (Ramaswamy & Musser, 1998; 
Gillespie, 2002; Viveiros et al., 2003).  
Some well-known drugs and their mechanism of actions affect bacteria in different ways. 
Streptomycin (STR) has been used to treat tuberculosis patients since the 1940s; INH was 
used to treat tuberculosis in the 1960s; RIF was first used at the beginning of the 1970s 
(Toungoussova et al., 2006); and ethambutol (EMB) was introduced in 1961 as a 
bacteriostatic first-line drug (Perdigão et al., 2009). RIF inhibits transcription to RNA and 
translation to proteins by binding its' beta subunit of RNA polymerase in bacteria; 
however, if bacteria produce a different beta subunit, they are not affected by the drug 
(O'Sullivan et al., 2005). STR is a protein synthesis inhibitor. STR interacts with a 30S 
subunit of ribosome and disrupts protein synthesis (Sharma et al., 2007; Springer et al., 
2001). Its mechanism of action starts with binding tightly to the phosphate backbone of 
16S rRNA in different domains and making contact with the S12 ribosomal protein; finally 
it causes misreading of the bacterial genetic code during translation (Carter et al., 2000; 
Hosaka et al., 2006). INH is activated by an enzyme, catalase-peroxidase, called KatG in 
M. tuberculosis. KatG, isonicotinic acyl and NADH form a complex that binds enoyl-acyl 
carrier protein reductase (InhA) and affects fatty acid synthase. The identification of an 
enoyl-acyl carrier protein (ACP) reductase plays a role in INH resistance named InhA. In 
this way, mycolic acid synthesis and cell wall development are inhibited (van Veen & 
Konings, 1998; Slayden & Barry, 2000; Suarez et al., 2009). As a result, when exposed to 
INH, Mycobacteria lose their acid-fastness and viability. Changes in the catalase-
peroxidase gene (katG) and the inhA genes have been defined as one of the mechanisms 
of drug resistance in M. tuberculosis (Morris et al., 1995; Heym et al., 1995; Mohamad et al., 
2004). EMB is a potent synthetic antimycobacterial agent that may cause optic neuropathy 
in patients (Kozak et al., 1998).  
EMB has a bacteriostatic effect and interferes with mycolic acid synthesis, phospholipid 
metabolism, and arabinogalactan synthesis (Kilburn et al., 1977; Takayama & Kilburn, 1989) 
and affects nucleic acid metabolism (Forbes et al.,, 1965). EMB has synergistic actions, when 
combined with other agents, against Mycobacterium avium (Inderlied and Salfinger, 1995). TB 
is currently one of the most serious infectious diseases all over the world. Antimycobacterial 
drugs cause unpleasant side effects and trigger changes in the antibiotic target, thereby 
reducing the efficacy of drug therapies. Mycobacteria have recently increased their virulence 
and tuberculosis (TB) is the most lethal infection in the world. Between 1980 and 2005, 90 
million cases of TB worldwide were reported to the WHO (World Health Organization) and 
over three in every thousand people die of TB, which is the highest rate in the world (Lall 
and Meyer, 1999). Yang et al. (2010) also reported that the prevalence of MDR-TB among the 
Chinese people has increased since 1985. The WHO stated, ‘‘The global incidence of TB was 
estimated to be 136 cases per 100,000 population per year in 2005. In addition, the WHO 
region of the Americas and the WHO African region represent a total of 8.8 million new 
cases of TB and 1.6 million deaths from TB every year” (World Health Organization, 2008a). 
There were 9.5 million TB-related child deaths globally in 2006 (World Health Organization, 
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2008b). Today, one of the most important global health problems is changes in behavior of 
TB, such as resistance to anti-TB drugs and the influence of the HIV epidemic (World Health 
Organization, 2008a). WHO Global TB Control (2009) reported that there were 
approximately 0.5 million cases of MDR-TB in 2007. The World Health Organization (2010) 
reported that there were 9.4 million new TB cases globally and approximately 1.7 million 
people died from TB. The organization also reported that 1.2 million people were living 
with HIV and 76% of these people were residing in the African region while 14% were 
living in the South East Asian region in 2009 (World Health Organization, 2010). In South 
Africa, TB is the most commonly notified disease and the fifth largest cause of death among 
the black population. The prevalence of TB continues to increase all over the world. 
Although the main reasons are known to be the human immunodeficiency virus (HIV) and 
the emergence of drug-resistant strains of TB (WHO, 2009), the other factors include 
poverty, drug addiction, inadequate health conditions and migration (Antunes et al., 2000; 
Merza et al., 2011). WHO reports (2011a) estimated that the risk of developing tuberculosis 
(TB) is between 20 and 37 times greater in people living with HIV than among the general 
population. In addition, infection with Human immunodeficiency virus type 1 (HIV-1) 
disrupts immunological control of Mycobacterium infections due to the loss of CD4+ T cells. 
Salte et al. (2011) reported that Mycobacterium avium is one of the most common 
opportunistic infections among AIDS patients. Snider et al. (1985) examined the 
transmission of MDR-TB strains from adult to child contacts and confirmed the progression 
of the disease by DNA fingerprint studies. INH-resistant strains caused much infection in 
children who were in contact with adults. 
Mycobacteria are Gram-resistant non-motile pleomorphic rods with a waxy cell wall. These 
bacteria include high lipid content within the cell wall (Wilbur et al., 2009; Jackson et al., 
2007), the complex lipids esterified with long-chain fatty acids. Myobacteria are referred to 
as acid fast Gram-positive due to their resistance to dilute acid and ethanol-based de-
colorization procedures and their lack of an outer cell membrane. When they are stained 
using concentrated dyes, combined with heat, they do not give up the color by the dilute 
acid and ethanol-based de-colorization procedures (Ryan & Ray, 2004).  
Some medicinal plants have been used to treat the symptoms of TB including Acacia nilotica, 
Cassine papillosa, Chenopodium ambrosioides, Combretum molle, and Euclea natalensis from 
Africa (Watt and Breyer-Brandwijk, 1962; Pujol, 1990; Lall & Meyer, 2001; Bryant, 1966).  
Natural products are an important source of new chemical compounds and, hopefully, 
therapeutic agents for many bacterial diseases. Lall and Meyer (1999) reported 
antimycobacterial activity of Euclea natalensis (Ebenaceae), which is rich in naphthoquinones, 
against drug-sensitive and drug-resistant strains of M. tuberculosis. Gordien et al. (2009) 
studied two terpenes, sesquiterpene and longifolene; and two diterpenes, totarol and trans-
communic acid, obtained from the aerial parts and roots of Juniperus communis. They reported 
that totarol showed the highest activity against Mycobacterium tuberculosis H37Rv and that 
longifolene and totarol exhibited the most activity against rifampicin-resistant variants. 
Phenolic compounds have some effects on microbial metabolism and growth, depending on 
their concentration and active compounds (Alberto et al., 2001; Reguant et al., 2000).  
Many studies have shown that phenolic compounds inhibit the growth of a wide range of 
Gram-positive and Gram-negative bacteria (Davidson et al., 2005; Estevinho et al., 2008) 
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Flavonoids are the most common group of polyphenolic compounds. Flavonoids are plant 
secondary metabolites with a fused ring system, which are found as glycosides in plants. Of 
the well-known flavonoids, apigenin has a calming effect, while quercetin and kaempferol 
have a sedative effect (Jäger & Saaby, 2011).  
In previous studies, flavonoids were reported to show antimicrobial (Cushnie & Lamb, 2006, 
2011), anti-allergic (Chen et al., 2010), anti-inflammatory (Seo et al., 2000), and anti-
carcinogenic (Lee et al., 2008) activities. Until 2004, it was suggested (Cushnie and Lamb, 
2005, 2011) that their antibacterial efficacy was dependent upon cytoplasmic membrane 
damage by perforation (Ikigai et al., 1993), inhibition of nucleic acid synthesis (Mori et al., 
1987) and disruption of energy metabolism due to NADH-cytochrome c reductase inhibition 
(Haraguchi et al., 1998). Currently, some other supporting mechanisms have emerged to 
indicate the role of flavonoids in antibacterial activity; these mechanisms include damage to 
the cytoplasmic membrane by generating hydrogen peroxide (Tamba et al., 2007; Kusuda et 
al., 2006; Sirk et al., 2008), inhibition of nucleic acid synthesis (Gradisar et al., 2007; Wang et 
al., 2010) and inhibition of ATP synthase (Chinnam et al., 2010). While Puupponen-Pimiä et 
al. (2001) reported that catechin, rutin and quercetin did not affect the growth of E. coli, 
Vaquero et al., (2007) reported that quercetin was the strongest inhibitor active against 
bacteria, dependent on concentration.  
Lamiaceae, also known as mint, is a family of flowering plants that includes 250 to 258 genera 
and approximately 6,000 to 6,970 species across the world (Zomlefer, 1994; Mabberley, 1997). 
The family has a cosmopolitan distribution and contains many plant species with culinary and 
medicinal purposes; examples of the former are basil, mint, rosemary, sage, savory, marjoram, 
oregano, thyme, lavender, and perilla (Naghibi et al., 2005). The Lamiaceae family of plants 
have been used since ancient times as folk remedies for various health problems such as 
common cold, throat infections, acaricidal, psoriasis, seborrheic eczema, hemorrhage, 
menstrual disorders, miscarriage, ulcer, spasm and stomach problems (Takayama et al., 2011; 
Loizzo et al., 2010;. Ribeiro et al., 2010). Their constituents, particularly diterpenoids and 
triterpenoids, have been found to have antiseptic, antibacterial, anti-inflammatory, cytotoxic, 
cardio-active and other properties (Ulubelen, 2003). 
In our previous studies, we tested more than 100 plant extracts, some of which showed 
antimycobacterial activity against Mycobacterium tuberculosis. In this study, in the light of our 
past experiences, we present a continuation of the testing of some of the plant extracts and 
the efficacy of their antimycobacterial properties. 
2. Materials & methods 
2.1 Plant materials 
Aerial parts (herbs in the flowering stage) of plants, Origanum acutidens (Hand.-Mazz.) 
Ietswaart, Origanum sipyleum L., Salvia viridis L., Salvia microstegia Boiss&Bal., Satureja boissieri 
Hausskn. ex Boiss., Stachys byzantina  C.Koch., Stachys cretica L., Stachys cretica subsp. smyrnaea 
Rech. fil., Thymus syriacus Boiss., and Thymus cilicicus Boiss&Bal.(endemic) were collected from 
different parts of Turkey between 2009 and 2010. The plants were identified by Assoc. Prof. Dr. 
F. Satil at Balıkesir University, Turkey. Voucher specimens were deposited in the herbarium of 
Balikesir University Department of Biology. Herbarium plant data, such as locality, altitude, 
and collection time and identification number of species are given in Table 1. 
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2.2 Preparation of plant extracts 
The plants [O. acutidens (60 g), O. sipyleum (66 g), Salvia viridis (12 g), S. microstegia (100 g), 
Satureja boissieri (101 g), Stachys byzantina  (65 g), S. cretica (37 g), S. cretica subsp smyrnaea (71 
g), T. syriacus (44 g), and T. cilicicus (85 g) (endemic)], were air-dried at room temperature. 
Extracts of dried plants were prepared by the sequential extraction method (Chan et al., 
2008) using 1 L of chloroform (CL), ethyl acetate (EA) and methanol (ME) at room 
temperature over a period of fifteen days. Finally, three extract fractions were obtained from 
each plants. The extracts were filtered through filter paper concentrated using a rotary 
evaporator and dried in vacuo at 40 ºC. They were stored at −20◦C until use. The total yields 
from chloroform (CL), ethyl acetate (EA) and methanol (ME) extracts were O. acutidens (0.57, 
0.74, 4.88g), O. sipyleum (2.14, 1.61, 5.50g), Salvia viridis (0.22, 0.15, 1.56 g), S. microstegia (8.17, 
0.77, 6.70g), Satureja boissieri (4.05, 1.08, 8.82g), Stachys byzantina  (7.69, 1.10, 5.15g), S. cretica 
(1.16, 0.59, 3.47g), S. cretica subsp. smyrnaea (1.92, 1.43, 6.92g), T. syriacus (1.80, 1.08, 2.85g), 
and T. cilicicus (2.37, 3.18, 5.35g) respectively. All stocks were stored at -20 ºC. To conduct 
antimicrobial activity tests, samples were dissolved in dimethyl sulfoxide (DMSO) and 
prepared at a concentration of 100 mg/mL. All the extracts used were sterilized by passing 
through a syringe filter (Sartorius, Ø 0.22 µm.) before use. 
2.3 Chemicals and samples 
Gradient grade MeOH and acetonitrile were purchased from MERCK. Gradient grade water 
(18m) was prepared using a Purelab Option-Q elga dv25 system. All standard stock 
solutions (1 mg/mL) were prepared by dissolving each compound in MeOH. Standards, 
rosmarinic acid, trans cinnamic acid, and ferulic acid were purchased from Aldrich, caffeic 
acid and gallic acid from Sigma-Aldrich and all other chemicals used were obtained from 
Sigma. All solutions were filtered through a membrane filters (Sartorius, Ø 0.22 µm.) before 
injection into the capillary.  
2.4 LC-MS conditions 
Analyses were performed with Agilent LC-MS system (1200 LC with a single quadrupole) 
with ESI source negative mode. Source parameters were optimized to provide highest 
sensitivity. The source parameters are: Gas temperature 350 °C, drying gas flow 12 l/min, 
nebulizer pressure 50 psi, capillary voltage 3500 V., seperation was carried by a C-18 column 
(EC-C18 4,6x50mm 2.7um). Mobile phases are A: Water (5 mM ammonium formate+ 0.5 % 
formic acid) and B (acetonitrile). The gradient program is: 5 % B for starting condition and 
increased up to 45 % B in 1 min, hold 2 min, increase % B to 95 from 3 to 6 min, hold 1 min 
and decrease % B to 5% at final step. Total run time is 12 min. Injection volume is 5 µl. The 
detection was accomplished using MS SIM mode. Scan mode is also used. The LC–MS 
analysis was based in a method described by Pérez-Magariño et al. (1999). 
2.5 Preparation of standards 
Twenty standards were used for quantitative and qualitative determination: trans-cinnamic 
acid [(Rt)  4.98 min], ρ-coumeric acid (Rt  3.95 min), vanillic acid (Rt  3.79 min), gallic acid (Rt 
1.89 min), caffeic acid (Rt  3.72 min), ferulic acid (Rt  3.99 min), ), apigenin (Rt  4.83 min), 
naringenin (Rt  4.85 min), luteolin (Rt  4.43 min), epicatechin (Rt  3.67 min), quercetin (Rt  4.42 
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min), carnosic acid (Rt. 8.55 min), chlorogenic acid (Rt  3.59 min), rosmarinic acid (Rt  3.97 
min), apigenin 7-glucoside (Rt 3.89 min), oleuropein (Rt 3.969 min), amentoflavone (Rt  5.16 
min), naringin (Rt  3.83 min), rutin hydrate (Rt  3.69 min), hesperidin (Rt  3.85 min). 
Calibration concentrations were 1,4,5 and 20 ppm except one, apigenin 7-glucoside,  was 0.9, 
1.8, 4.5, 9, and 18 ppm and injection volume was 5 µL for all standards. 
2.6 Organisms 
The extracts were screened against four strain, M. tuberculosis H37Ra (ATCC 25177), M. 
tuberculosis H37Rv (ATCC 25618) and two-positive M. tuberculosis isolates obtained from 
patient from hospital, for antibacterial activity. 
2.7 Preparation of Mycobacterium tuberculosis inocula 
Bacterial suspensions of M. tuberculosis were prepared either from Lowenstein–Jensen slants 
or from complete 7H9 broth cultures. To prepare an inoculum that was less than 15 days old 
from a culture grown on Lowenstein-Jensen medium, a suspension was prepared in 
Middlebrook 7H9 broth. The turbidity of the suspension was adjusted to a 1.0 McFarland 
standard. The suspension was vortexed for several minutes and was allowed to stand for 20 
min for the initial settling of larger particles. The supernatant was transferred to an empty 
sterile tube and was allowed to stand for an additional 15 min. After being transferred to a 
new sterile tube, the suspension was adjusted to a 0.5 McFarland turbidity standard by 
visual comparison. One mL of the adjusted suspension was diluted in 4 mL of sterile saline 
solution. 
No 
Genus species authority 
(Lamiaceae) 
Locality 
Altitude 
(m) 
Collection 
Time 
Herbarium 
Number 
1 
Origanum acutidens  
(Hand.-Mazz.) Ietswaart. 
Between Elazig-
Erzincan 
1230 15.Jul.2009 FS 1605 
2 Origanum sipyleum L. 
Between Balıkesir-
Savastepe 
200 02.Jul.2009 FS1561 
3 Salvia viridis L. Balikesir-Cagis 160 02. Jun.2010 FS1560 
4 
Salvia microstegia
Boiss&Bal. 
Van, Gurpinar 1100 26.Jun.2009 FS 1559 
5 
Satureja boissieri Hausskn.  
ex Boiss. 
Adiyaman-Yazibaşı 
village 
980 20.Sep.2010 FS1562 
6 
Stachys byzantine  
C.Koch. 
Bursa, Mezitler 860 08.Jul.2009 FS1602 
7 Stachys cretica L. 
Balikesir-Edremit, 
Kazdagi, 
350 23.Jun.2009 FS1603 
8 
Stachys cretica subsp. 
smyrnaea Rech.fil. 
Balikesir-Edremit, 
Kazdagi, 
1260 17.Jul.2009 FS1604 
9 Thymus syriacus Boiss. 
Gaziantep-Burc 
forest 
850 03.Aug.2009 FS1558 
10 
Thymus cilicicus 
Boiss&Bal.(endemic) 
Antalya, Belek 1000 12.Jul.2010 FS1556 
Table 1. Herbarium data of plants  
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To prepare M. tuberculosis inoculum using a BACTEC MGIT tube with positive growth, the 
positive tubes were used beginning from the day after the sample first became positive 
(day-1 positive), up to and including the fifth day (day-5 positive). The positive tubes that 
were older than five days were subcultured into fresh growth medium. Tubes that were 
day-1 and day-2 positive were used in the inoculation procedure for the susceptibility tests. 
The tubes that were between day-3 and day-5 positive were diluted using 1 mL of the 
positive broth and 4 mL of sterile saline solution; the 5 mL diluted suspension samples were 
used for the inoculation procedures. 
2.8 Antimycobacterial activity test 
Antimycobacterial bioassay was performed using the Microplate Alamar Blue Assay 
(MABA) method (Collins and Franzblau, 1997). MIC was recorded as the lowest drug 
concentration that prevented to turn blue to pink colour by adding Alamar blue. MBC was 
also recorded the minimum extract concentration that do not cause any color changing in 
cultures reincubated in fresh medium. 
2.8.1 Determination of Minimal Inhibitory Concentrations (MICs) for Mycobacterium 
tuberculosis 
Microplates were inoculated with the bacterial suspension (20 μL per well except for the 
negative control wells) and incubated at 37 °C for 6 days. Alamar blue (15 μL, Trek 
Diagnostic system) was then added to the bacterial growth control wells (without extract) 
and the microplates were incubated at 37 °C for an additional 24 hours. If the dye turned 
from blue to pink, (indicating positive bacterial growth) then Alamar blue solution was 
added to the other wells to determine the MIC values. All tests were performed in triplicate.  
2.8.2 Determination of mycobactericidal activity 
All the extracts prepared from aerial parts of plants, the herbarium data of these species 
shown in Table 1, were analyzed by LC-MS. The quantity of chemicals in the methanol 
extracts are given in Table 2.  Chromatograms of phenols in all extracts were compared to 
chromatograms of standards (Figs. 1–3). 
The plant extracts described above were used in mycobactericidal activity tests. Two-fold 
dilution series in triplicate sets of parallel microplate wells were used for each extract. To 
determine the minimum bactericide concentrations (MBCs), fresh Middlebrook 7H9 culture 
broth (185 μL) was transferred to each well. A fifteen microliter of an Mycobacterial 
suspension, from MIC concentration and higher concentration wells obtained from the MIC 
test described above was added to each well, in order to determine the minimum bactericide 
concentration (MBC). 
Two microplate wells were used as positive and negative controls, and each test was 
repeated in triplicate. For the negative controls, 200 mL of fresh broth (Middlebrook 7H9 
culture medium and OADC) was used. For positive controls, including 185 μL and 
inoculums from former positive control wells (15 μL) was used. After 24 hours of incubation 
and colour development using the Alamar blue solution, MBCs were recorded as the 
minimum extract concentration that did not cause any colour change in cultures when 
reincubated in fresh medium. 
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3. Results  
3.1 Phenolics determined by LC-MS analyses 
The ten samples and selected standards were analyzed by MS in ESI negative ion mode. 
Scan mode is also used. In this method, trans-cinnamic acid, p-coumaric acid, vanillic acid, 
gallic acid,  caffeic acid, ferulic acid,  apigenin,  naringenin, luteolin, epicatechin, quercetin, 
carnosic acid, chologenic acid, rosmarinic acid, apigenin 7-glucoside, amentoflavone,  
oleuropein,  naringin, rutin hydrate and hesperidin were chosen as standard phenolics to 
determine the phenolic structures of the samples according to ionization response in ESI 
mass spectrometry and chromatographic retention time. 
Ion profile of negative ion electrospray LC/MS analysis experimental conditions are given 
above, from plants CL, EA and ME extracts is shown Fig. 1-2 and Table 2. Phenolics of 
samples were identified by comparing standard phenolic data such as retention times, main 
ions observed under fragmentation voltage of 80 Volt. 
No Phenolics Rt min [M-H]- Fragment ions 
1 trans-Cinnamic acid 4,984 147 80 
2 ρ-Coumaric acid 3,95 163 80 
3 4-Hydroxy-3-metoxybenzoic acid (vanillic acid) 3,747 167 80 
4 Gallic acid monohyrate 1,893 169 80 
5 Caffeic acid 3,724 179 80 
6 Ferulic acid 3,991 193 80 
7 Apigenin 4,831 269 80 
8 (+)-Naringenin 4,859 271 80 
9 Luteolin  4,433 285 80 
10 (-)-Epicatechin 3,675 289 80 
11 Quercetin  4,427 301 80 
12 Carnosic acid 8,555 331 80 
13 Chlorogenic acid 3,597 353 80 
14 Rosmarinic acid 3,971 359 80 
15 Apigenin 7-glucoside 3,896 431 80 
16 Amentoflavone  5,169 537 80 
17 Oleuropein  3,969 539 80 
18 Naringin  3,834 579 80 
19 Rutin hydrate 3,699 609 80 
20 Hesperidin 3,853 609 80 
Table 2. LS-MS characteristics of phenolic compounds  
The major phenolic compounds of T. cilicicus CL extract were rutin hydrate and naringenin; 
for EA extract, rosmarinic acid and apigenin; and for ME extract, rosmarinic acid, oleropein, 
and apigenin. 
The highest rosmarinic acid level within all plants were determined in S. viridis for CL 
extracts; in S. boissieri and T. cilicicus for EA extracts; O. sipyleum S. byzantine and S. boissieri 
for ME extracts.   
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Fig. 1. ESI-MS Spectra of standard phenolics, 1; trans-cinnamic acid 2; p-coumaric acid 3; 
vanillic acid 4; gallic acid 5; caffeic acid 6; ferulic acid 7; apigenin 8; naringenin 9; luteolin 10; 
epicatechin 11; quercetin 12; carnosic acid 13; chlorogenic acid 14; rosmarinic acid 15; 
apigenin 7-glucoside 16; amentoflavone 17; oleuropein 18; naringin 19; rutin hydrate 20; 
hesperidin 
 
Fig. 2. ESI-TIC SIM chromatogram of standard phenolics, 1; trans-cinnamic acid 2; p-
coumaric acid 3; vanillic acid 4; gallic acid 5; caffeic acid 6; ferulic acid 7; apigenin 8; 
naringenin 9; luteolin 10; epicatechin 11; quercetin 12; carnosic acid 13; chlorogenic acid 14; 
rosmarinic acid 15; apigenin 7-glucoside 16; amentoflavone 17; oleuropein 18; naringin 19; 
rutin hydrate 20; hesperidin 
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Fig. 3. ESI-TIC SIM chromatogram of O.sipyleum A) EA extract, B) ME extract; S. boissieri C) 
CL extract D) EA etract and E) ME extract. (Not all chromatograms are included). 
The major phenolic compounds for T. syriacus were rutin hydrate and naringenin for CL 
extract; rosmarinic acid, apigenin naringenin, and vanillic acid for EA extract; rosmarinic 
acid, apigenin, luteolin, and oleropein for ME extract. 
The major phenolic compounds of O. acutidens determined by LC-MS analyses were rutin 
hydrate for the CL extracts; rosmarinic acid and oleuropein for the EA extracts, rosmarinic 
acid; and vanillic acid for the ME extracts. The major phenolics of O. sipyleum were rutin 
hydrate for CL extracts; rosmarinic acid and vanillic acid for EA and ME extracts. The major 
phenolics of CL extracts of S. viridis were rosmarinic acid and rutin hydrate; for EA extracts, 
oleuropein followed by rosmarinic acid; for ME extracts, rosmarinic acid, chlorogenic acid 
and hesperidin. 
The major phenolic compounds for S. microstegia were rutin hydrate for CL extracts; 
apigenin, luteolin, and rosmarinic acid for EA extract; and rosmarinic acid, apigenin and 
luteolin for ME extracts. In S. boissieri, the major phenolics for CL extracts were apigenin and 
naringenin; for EA extracts, rosmarinic acid, naringenin and hesperidin; for ME extracts, 
rosmarinic acid and hesperidin (Fig 3). The major phenolic compounds in the CL extracts of  
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S. byzantina were rutin hydrate; in the EA extract, apigenin, luteolin and rosmarinic acid; 
and in the ME extract, rosmarinic acid, hesperidin and apigenin.  
In S. cretica, the major phenolics in the CL extracts were trans-cinnamic acid and vanillic 
acid; oleuropein, vanillic acid and rosmarinic acid for EA extract; and chlorogenic acid and 
rosmarinic acid for ME extract. In S. smyrnaea, the major phenolics were rosmarinic acid and 
rutin hydrate for CL extracts; vanillic acid and chlorogenic acid for EA extract; chlorogenic 
acid and hesperidin for ME extracts.  
The highest rutin hydrate contents were determined in O. sipyleum and S. viridis for CL 
extracts; T. cilicicus, S. viridis, and S. boissieri for EA extracts; S. cretica subsp. smyrnaea, S. 
byzantina, and T. syriacus for ME extracts.  
Gallic acid was determined only in methanol extracts of S. viridis. Carnosic acid was also 
found in CL extract of S. boissieri. Only the EA extracts of S. microstegia, S. byzantina, T. 
cilicicus and T. striacus included the highest level of apigenin.  
Trans-cinnamic acid was found in extracts of four plants (O. acutidens, S. byzantina, and S. 
cretica subsp. smyrnaea). Quercetin and amentoflavone were not found. The highest level of 
chlorogenic acid was found in ME extracts of S. cretica subsp. smyrnaea, S. cretica, and S. 
viridis. Luteolin occurred mostly in EA and ME extracts in S. microstegia, S. byzantina, and T. 
cilicicus. The highest hesperidin level was found in S. boissieri ME extract and it follows S. 
byzantina ME extracts; In addition, ME extracts of S. viridis and T. cilicicus also included high 
levels of hesperidin. The highest oleuropein content was determined in ME extracts of T. 
cilicicus, followed by T. syriacus and S. boissieri. Within EA extracts, S. viridis and O. acutidens 
had the highest level of oleuropein.  
3.2 Antimycobacterial activities, MICs & MBCs 
The results were evaluated according to the literature. Extracts were tested against four 
mycobacteria strains (M. tuberculosis H37Ra, M. tuberculosis H37Rv, and two-positive M. 
tuberculosis isolates) obtained from hospital patients, to determine the MIC and MBC using 
the micro dilution method (MABA) against reference strains.   
All plant extracts showed antimycobacterial activity (Table 4). Within all CL extracts, O. 
acutidens, S. microstegia, and T. syriacus exhibited the lowest MIC value of 0.4 mg/mL against 
M. tuberculosis H37 Ra. The lowest MBC value was 6.3 mg/mL for O. acutidens and S. 
boissieri. The MBC value for the rest of species was 12.5 mg/mL.  
The MIC value of CL extracts against M. tuberculosis H37 Rv was 0.4 mg/mL for S. boissieri, 
followed by S. cretica, T. syriacus, and T. cilicus at MIC 6.3 mg/mL. Although all CL extracts 
showed bactericidal activity against M. tuberculosis H37 Rv, the prominent MBC values are 
0.8 mg/mL for S. boissieri and 3.1 mg/mL for T. syriacus. For TB-positive isolates1, the 
featured results were 0.8 mg/mL MIC and MBC for S. boissieri and 3.1 mg/mL MIC and 
MBC for S. cretica subsp. smyrnaea. S. boissieri was also effective at the concentration 0.8 
mg/mL as MBC. 
In the EA extracts, the most prominent efficacy was observed for T. syriacus at MIC 0.8 
mg/mL; MBC 1.6 mg/mL for T. syriacus against M. tuberculosis H37 Ra. S. boissieri is also 
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effective at MIC and MBC 6.3 mg/mL against two TB-positive isolates; T. cilicus showed the 
same effect at MIC and MBC 3.1 on M. tuberculosis H37 Rv. 
Of the ME extracts, the most effective against M. tuberculosis H37 Ra was T. syriacus (MIC 
and MBC 3.1 mg/mL). Stachys byzantine also showed considerable efficacy at MIC 3.1 
mg/mL against TB-positive isolates1. Among the other extracts, MIC and MBC values 
ranged between 6.3-12.5 and 6.3-25 mg/mL, respectively (Table 4). 
 
Plants Extracts
H37Ra H37Rv Isolate1 Isolate2 
MIC MBC MIC MBC MIC MBC MIC MBC 
Origanum  acutidens 
Cl 0.4 6.3 12.5 12.5 12.5 25 6.3 6.3 
Ea 6.3 6.3 6.3 6.3 3.1 6.3 3.1 6.3 
Me 6.3 6.3 25 25 3.1 12.5 6.3 12.5 
O. sipyleum 
Cl 3.1 12.5 25 25 12.5 25 6.3 12.5 
Ea 1.6 3.1 25 25 6.3 25 6.3 25 
Me 12.5 12.5 25 25 6.3 12.5 6.3 6.3 
Salvia viridis 
Cl 6.3 12.5 12.5 12.5 n.t n.t n.t n.t 
Ea 1.6 3.1 12.5 12.5 6.3 12.5 6.3 12.5 
Me 12.5 12.5 25 25 6.3 25 6.3 25 
S. microstegia 
Cl 0.4 12.5 12.5 12.5 12.5 25 6.3 12.5 
Ea 6.3 12.5 25 25 3.1 12.5 3.1 12.5 
Me 12.5 12.5 12.5 25 6.3 25 6.3 25 
S. boissieri 
Cl 0.8 6.3 0.4 0.8 0.8 0.8 0.8 0.8 
Ea 1.6 3.1 12.5 12.5 3.1 3.1 3.1 3.1 
Me 12.5 12.5 12.5 12.5 6.3 12.5 6.3 12.5 
Stachys byzantine 
Cl 0.8 12.5 25 25 12.5 25 6.3 6.3 
Ea 12.5 12.5 12.5 12.5 3.1 6.3 6.3 12.5 
Me 12.5 12.5 25 25 3.1 12.5 6.3 25 
S. cretica 
Cl 0.8 12.5 6.3 12.5 12.5 12.5 6.3 12.5 
Ea 1.6 12.5 6.3 12.5 3.1 12.5 3.1 12.5 
Me 12.5 12.5 12.5 12.5 6.3 25 6.3 25 
S. cretica subsp. smyrnaea 
Cl 6.3 12.5 12.5 12.5 3.1 3.1 6.3 12.5 
Ea 6.3 12.5 12.5 12.5 3.1 12.5 3.1 12.5 
Me 25 25 12.5 12.5 3.1 25 3.1 25 
Thymus syriacus 
Cl 0.4 12.5 6.3 12.5 6.3 6.3 3.1 6.3 
Ea 0.8 1.6 3.1 3.1 3.1 12.5 3.1 12.5 
Me 3.1 3.1 50 50 6.3 12.5 6.3 25 
T. cilicicus 
Cl 0.8 12.5 6.3 25 6.3 25 6.3 12.5 
Ea 3.1 6.3 3.1 6.3 3.1 25 3.1 25 
Me 12.5 12.5 12.5 12.5 6.3 25 6.3 25 
MIC:( mg/mL); MBC: ( mg/mL;). n.t: not tested. 
Table 4. Antibacterial activity of extracts of the plants as MIC (mg/mL) and MBC 
susceptibility test results against M. tuberculosis H37Ra (ATCC 25177) and M. tuberculosis 
H37Rv (ATCC 25618) obtained by MABA (Microplate Alamar blue assay) method.  
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4. Discussion 
Lamiaceae plant extracts prepared by using different plant parts such as bark, stem, root, 
leaves, and fruits used in many biological activity studies. The extracts have been found to 
have antibacterial activity (Alma et al., 2003; Amanlou et al., 2004; Digrak et al., 2001; Bozin 
et al., 2006; Karaman et al., 2001), antifungal activity (Bouchra et al., 2003; Askun et al., 2008; 
Gulluce et al., 2003; Guynot et al., 2003; Souza et al., 2005), antimycobacterial activity 
(Ulubelen et al., 1997; Askun et al., 2009), antioxidant activity (Alma et al., 2003; Bozin et al., 
2006; Mosaffa et al., 2006; Gulluce et al., 2003) and anti-inflammatory activity (Alcar´az et al., 
1989; Jim´enez et al., 1986). Inhibitory effects of oregano components on some foodborne 
fungi were reported (Akgul & Kivanc, 1988). Askun et al. (2009) indicated that Origanum 
minutiflorum and Thymbra spicata methanol extracts showed antimycobacterial activity 
against M. tuberculosis. T. spicata var. spicata showed greater antimycobacterial efficacy (at 
MIC 196 µg/ml) than O. minutiflorum (MIC 392 µg/ml). They stated that a high quantity of 
rosmarinic acid might be responsible for antimycobacterial activity.  
Recently, investigations of plant extracts are attracting great attentions due to their 
antibacterial properties (Payne et al., 2007; Rukayadi et al., 2009; Guzman et al., 2010). 
Previous studies showed that some plant extracts were conciderably effective against M. 
tuberculosis. Lall and Meyer (1999) reported that growth of M. tuberculosis is inhibited by 
acetone and water extracts of Cryptocarya latifolia, Euclea natalensis, Helichrysum melanacme, 
Nidorella anomala and Thymus vulgaris. They screened these active acetone extracts against 
H37Rv and a TB strain that was resistant to the drugs isoniazid and rifampicin. They 
reported that, while some plants (Croton pseudopulchellus, Ekebergia capensis, Euclea natalensis, 
Nidorella anomala and Polygala myrtifolia) exhibited MIC at 0.1 mg/mL against H37Rv, others 
(Chenopodium ambrosioides, Ekebergia capensis, Euclea natalensis, Helichrysum melanacme, 
Nidorella anomala and Polygala myrtifolia) inhibited the resistant strain at the same MIC value.  
Many natural products have attracted much attention as potential antimycobacterial agents 
(Kinghorn, 2001; Gupta et al., 2010; Guzman et al., 2010). In recent years, there are pleny of 
researches on phenolics and their biological activities involved in the literature. Phenolic 
compounds obtained from plant extracts show great variety, with at least 8000 different 
structures (Bravo, 1998). Estevinho et al. (2008) showed that differences in the profiles of 
phenolic compounds are dependent of the flora predominance. Chun et al. (2005) reported 
that high phenolic and antioxidant activity was related to high antimicrobial activity against 
ulcer-associated H. pylori. Cinnamic acid is a naturally occurring phenolic compound that 
shows antimicrobial activity. Chen et al. (2011) showed that cis-cinnamic acid that was 
transformed from trans-cinnamic acid showed higher synergistic effect with INH or RIF 
against tuberculosis than trans-cinnamic acid. 
Siedel & Taylor (2004) investigated plants, Pelargonium reniforme and P. sidoides 
(Geraniaceae) fractionation of n-hexane extracts against M. aurum, M. smegmatis, M. 
fortuitum, M. abscessus and M. phlei. They reported that linoleic acid was the most potent 
compound (MIC of 2 mg/l) against M. aurum. Koysomboon et al. (2006) isolated flavonoids 
from the stems and roots of the mangrove plant Derris indica. They reported 
antimycobacterial activity at MIC values between 6.25 and 200 µg/mL, except in two of ten 
known compounds. Askun et al. (2009) indicated that Origanum minutiflorum and Thymbra 
spicata var. spicata methanol extracts have antimycobacterial activity against M. tuberculosis. 
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T. spicata var. spicata was more effective (MIC 196 µg/ml) than O. minutiflorum (MIC 392 
µg/ml). They suggested that a high quantity of rosmarinic acid might be one of the 
responsible constituent for the observed antimycobacterial activity. Gordien et al. (2009) 
studied two terpenes, sesquiterpene and longifolene; and two diterpenes, totarol and trans-
communic acid, obtained from the aerial parts and roots of Juniperus communis. They 
reported that totarol showed the highest activity against Mycobacterium tuberculosis H37Rv 
and that longifolene and totarol exhibited the most activity against rifampicin-resistant 
variants. These results supported the ethnomedicinal use of this species as a traditional anti-
TB remedy. Kuete et al. (2010) investigated the antimycobacterial activity of five flavonoids 
(isobachalcone, kanzanol C, 4-hydroxylonchocarpin, stipulin, amentoflavone) and 
determined their effects on preventing the growth of mycobacteria with MIC < 10 µg/ml on 
M. tuberculosis. In addition, isobachalcone and stipulin showed total inhibition of M. 
tuberculosis strain H37Rv. Bernard et al. (1997) mentioned that rutin showed antibacterial 
activity on E. coli by inhibited topoisomerase IV-dependent decatenation activity and caused 
E. coli topoisomerase IV which is essential for cell survival, dependent DNA cleavage 
(Bernard et al., 1997; Normark et al., 1969; Cushnie& Lamb., 2005). Huang et al. (2008) 
indicated that evidence that vanillic acid might be helpful to prevent of the development of 
the development of diabetic neuropathy by blocking the methylglyoxal-mediated glycation 
system. 
Mandalari et al. (2007) also reported that, pair-wise combinations of eriodictyol, naringenin 
and hesperidin showed both synergistic and indifferent interactions that were dependent on 
the test indicator organism and their cell wall structure. Parekh and Chanda (2007) reported 
that the crude methanol extract of Woodfordia fruticosa contains certain constituents, such as 
tannins, with significant antibacterial properties, which enables the extract to overcome the 
Gram-negative cell wall barrier. 
Kamatou et al. (2007) studied 16 South African Salvia species that are used in traditional 
medicine to treat microbial infection. They identified three species, S. verbenaca, S. radula and 
S. dolomitica, which exhibited MIC value at 0.10 mg/mL and which also showed 
antibacterial activity. Green et al. (2010) reported on the activities of acetone extracts of four 
plants, while Berchemia discolor showed efficacy at MIC 12. 5µg/mL, on H37Ra and 
10.5µg/mL on the clinical isolate; the others (Bridelia micrantha, Warbugia salutaris, and 
Terminalia sericea) showed efficacy at 25µg/mL on both H37Ra and clinical isolate. The 
authors validated that these plants include mycobactericidal compounds that are effective 
against multidrug-resistant M. tuberculosis. Graham et al. (2003) presented an 
antimycobacterial evaluation of 216 species of Peruvian plants (in 63 families). 
Dichloromethane extracts from slightly more than half of the samples tested showed MIC 
value at 50 μg/ml concentration against M. tuberculosis. Billo et al. (2005) reported that 
methanolic extract of Amborella trichopoda fruits shows MIC value between 1 and 2.5 µg/ml, 
which was better than pyrazynamide and ethambutol in the same conditions. 
Fabryet et al. (1998) reported that solvent extracts of plants with MIC values less than 8 
mg/mL may be considered as antimicrobially effective. Gautam et al., (2007), shows that 
extracts of plant species from wide range of families and genera have exhibited significant in 
vitro antimycobacterial activities and this efficacy is interestingly compatible with the 
ethnomedicinal knowledge on plants.  
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Lechner et al. (2008) showed that myricetin was the most efficient intensifier of INH 
susceptibility in all tested strains by decreasing the MIC value of INH by as much as 64-fold; 
the second most effective compound was quercetin. Huang et al. (1980) tested two 
benzenoid compounds isolated from Ardisia japonica in-vivo on 201 patients infected with M. 
tuberculosis (Okunade et al., 2004). They reported that both compounds showed over 80% 
efficacy.  
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6. Conclusion 
In order to test the plant extracts, a potential drug resistant M. tuberculosis isolates was 
obtained from pulmonary tuberculosis hospital patients. The strains and isolates were then 
treated with plant extracts that are used for ethnopharmacological purposes. The level of the 
phenolic compounds and some flavonoids extracts were determined by liquid 
chromatography–mass spectrometry (LC-MS). The evaluation of results included the plants 
efficacy, their major phenolics, flavonoids and antimycobacterial activities. All plants extract 
showed antimycobacterial activity. 
O. acutidens, S. microstegia, and T. syriacus were exhibited the lowest MIC value at 0.4 mg/mL 
against M. tuberculosis H37 Ra. S. boissieri and T. syriacus showed activity at MIC 0,4 mg/mL 
against M. tuberculosis H37 Rv. The prominent MIC and MBC values against M. tuberculosis 
H37 Rv were determined at 0,8 mg/mL for S. boissieri and 3,1 mg/mL for S. cretica subsp. 
smyrnaea. S. boissieri and T. cilicicus were effective against two TB-positive isolates. 
The present work provides a preliminary insight into the effects of phenolics against M. 
tuberculosis. Plants of the Lamiaceae family have been shown to include new and effective 
constituents against Mycobacterium tuberculosis. Examination of these species, reported 
above, shows that rutin hydrate and vanillic acid were plentiful in all three extracts for these 
genera in Lamiaceae. All extracts of the Origanum species, Salvia, Satureja, Stachys and 
Thymus genera were rich in rosmarinic acid. With the exception of S. viridis, these species 
did not contain gallic acid.  
We suggest that phenolics and naturally occurring flavonoids (polyphenols) are mainly 
responsible for antimycobacterial, cytotoxicological and mutagenic activity against M. 
tuberculosis. In some plants, (O. acutidens, O. sipyleum, S. microstegia, and Stachys byzantine) 
MIC and MBC values of CL extracts were in the same concentrations. These results might be 
due to several factors, such as a toxic effect caused by some compounds in the extracts. Liu 
et al. (2010) showed that a high concentration of cinnamic acid has toxic effects on soil 
bacteria. The other reason might be that the primary targets of the flavonoids have not been 
studied as widely in bacteria as in eukaryotes. While flavonoids affect enzyme systems such 
as prostaglandin, cyclooxygenase and lipoxygenase in eukaryotic cells, the bacteriocidal 
effect of the flavonoids might have caused the metabolic disorders on metalloenzymes by 
which their heavy metal atoms combine with flavonoids as ligand complexes in bacteria. 
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These strong complexes might disrupt the metabolism of organism (Havsteen, 2002). 
Flavonoids are also known to have mutagenic and antitumor activities (Hodec et al., 2002; 
Havsteen, 2002). Quercetin affects bacteria by inhibiting the catalytic activity of DNA 
topoisomerase I and II (Constantinou et al., 1995; Hodec et al., 2002). Quercetin was also 
reported by Xu et al. (2000) and Spedding et al. (1989) to have inhibitory effects on HIV1-
protease and reverse transcriptase. 
It is imperative to investigate the use of new, cheaper and efficient compounds to control 
Mycobacteria tuberculosis. Recent studies have examined plants and the effectiveness of their 
different types of extracts on M. tuberculosis. Advanced research into the structure and 
activity relationships among naturally occurring flavonoids will yield greater understanding 
of their pharmacokinetics and effects on mycobacteria metabolism according to their 
structure. It is of great importance to determine the mechanisms of action of flavonoids on 
M. tuberculosis . 
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